More than 300,000 of Centinel Spine’s prodisc cervical and lumbar total disc replacement implantations have been performed worldwide.
The milestone marks over three decades of clinical use for the company’s prodisc-brand platform, according to a Nov. 13 news release.
Centinel Spine also highlighted recent regulatory and product milestones, including FDA approval for two-level indications of its prodisc L lumbar and prodisc C Vivo and SK cervical devices.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
